Document is current

Rivastigmine Transdermal Patch 13.3 mg/24 h: A Review of Its Use in the Management of Mild to Moderate Alzheimer’s Dementia

Crossref DOI link: https://doi.org/10.1007/s40266-014-0197-x

Published Online: 2014-07-03

Published Print: 2014-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy